Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of tumor suppressor gene-modified mesenchymal stem cells

A mesenchymal stem cell and gene modification technology, which is applied in the field of mesenchymal stem cell preparation, can solve the problems of immunogenicity limiting repeated administration, low immunogenicity, limiting the development and application of tumor gene therapy, and solving the problem of inability to efficiently target Delivery and safety issues, high infection rate and co-expression efficiency, good tumor targeting effects

Inactive Publication Date: 2014-12-24
SHENZHEN WINGOR BIO TECH
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Viruses have safety risks, such as causing insertion mutations, forming anti-DNA antibodies, local infection, and causing tumor nodules and ulcers, etc., and their immunogenicity also limits repeated administration
Non-viral gene targeting delivery carriers, such as liposomes, magnetic nanoparticles, cationic polymers, and polymer vesicles, have low immunogenicity and good biocompatibility, but there are still shortcomings, such as The gene transfer efficiency mediated by non-viral vectors is low, the particle size distribution of magnetic nanoparticles is uneven, and it is easy to form aggregates to block capillaries. Liposomes themselves are rapidly recognized and cleared in the bloodstream by the reticuloendothelial system, limiting their further application as gene carriers
Therefore, the safety, targeting, low transfection efficiency, and short expression time of existing viral and non-viral gene carriers limit the development and application of tumor gene therapy. Currently, it is necessary to develop safer and more efficient gene carriers to support Related scientific research and clinical application of tumor gene therapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of tumor suppressor gene-modified mesenchymal stem cells
  • Preparation method of tumor suppressor gene-modified mesenchymal stem cells
  • Preparation method of tumor suppressor gene-modified mesenchymal stem cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0064] The present invention will be described in further detail below in conjunction with the accompanying drawings and specific embodiments.

[0065] Isolation and culture of mesenchymal stem cells (MSCs)

[0066] (MSCs include but are not limited to MSCs derived from human fat, umbilical cord, cord blood, placenta, bone marrow, dental pulp, etc. The example takes human adipose-derived mesenchymal stem cells-hAMSCs as an example)

[0067] (1) Isolation of hAMSCs and culture of primary and passage

[0068] Fat samples were obtained from healthy donors who underwent liposuction in cosmetic plastic surgery clinics. Take 20ml of adipose tissue obtained by liposuction, first digest it with 0.075% collagenase for 30 minutes, and filter the digested mixed liquid through a 200-mesh cell sieve, and wash the filtered cells twice with DMEM / F12 medium, respectively in Centrifuge at 1500rpm for 10 minutes at room temperature for cell enrichment, resuspend the cells in complete medi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method for tumor suppressor gene-modified mesenchymal stem cells. The method comprises the following steps: A) separation of MSCs and primary culture and subculture; B) building of a tumor suppressor gene recombinant vector; and C) expression and identification of the tumor suppressor gene in MSCs. According to the method, recombination of a target tumor suppressor gene is carried out by adopting an adenovirus vector, the target gene is jointly expressed in the MSCs after the recombinant plasmid transfects the MSCs, and the preparation method has high infection rate and coexpression efficiency. Compared with other virus vectors, the vector disclosed by the invention has the advantages that the adenovirus transduction efficiency is relatively high, and fissional stem cells can be efficiently transfected, and the vector is not integrated into chromosome. Therefore, the safety is relatively high.

Description

[0001] technical field [0002] The invention belongs to the technical field of preparation of mesenchymal stem cells, in particular to a method for preparing mesenchymal stem cells modified by tumor suppressor genes. [0003] Background technique [0004] Gene therapy refers to a new biomedical technology that introduces genes with normal functions or genes with therapeutic effects into target cells in a certain way to correct gene defects or exert therapeutic effects, so as to achieve the purpose of treating diseases. The principle of tumor gene therapy is to introduce the target gene into target cells with gene transfer technology, so that it can obtain specific functions, and then execute or mediate the killing and inhibition of tumors, or protect normal cells from the serious effects of chemotherapy and radiation therapy. harm. According to different treatment strategies, the target gene can be proto-oncogene or antisense nucleic acid of tumor autocrine growth factor ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/861
Inventor 姜舒张芸罗朝霞刘颖斐
Owner SHENZHEN WINGOR BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products